Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 283 results found. Search for [ remdesivir ]

Results 1 to 21 of 283
BusinessToday.In
February 4, 2021
Out of the millions of cases around the world, one coronavirus case has stood out. The case is of a 45-year-old Covid-19 patient from Boston who died last summer after fighting for 154 days of illness--one of the longest on record


BusinessToday.In
January 30, 2021
COVID-19 vaccination drive: Health Ministry Additional Secretary Manohar Agnani informed the states and UTs that the database of frontline workers is being updated in collaboration with respective line ministries


BusinessToday.In
January 28, 2021
Coronavirus pandemic: A group of Chinese researchers published a study in the Future Microbiology journal in August that said that some recovering patients tested positive through anal swabs but negative through throat swabs


BusinessToday.In
January 27, 2021
Coronvirus treatment: Plitidepsin, according to the researchers, should be considered for clinical trials based on its in vivo study results. Plitidepsin aka Aplidin is owned by Spanish pharmaceutical company Pharma Mar


PTI
January 22, 2021
So far, India has sent consignments of coronavirus vaccines under grant assistance to Bhutan, Maldives, Nepal, Bangladesh, Myanmar, Mauritius and Seychelles


PTI
January 20, 2021
It is learnt that 1,50,000 doses of Covisheild vaccine, manufactured by the Serum Institute of India (SII), were sent to Bhutan and 1,00,000 doses reached Maldives as part of India's grant assistance


PTI
January 3, 2021
A study suggests that chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19


PTI
December 27, 2020
The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing the vaccine


BusinessToday.In
December 16, 2020
Rapid antigen detection test directly detects presence or absence of coronavirus antigen in patient's body, generating results in 15-20 minutes; ICMR-approved CIPtest is found to have specificity and sensitivity of 98.09 per cent and up to 75 per cent


Joe C Mathew
December 2, 2020
Of the 8,936 respondents, 59 percent say they will not rush to vaccinate themselves against the pandemic even if it is made available by February 2021


BusinessToday.In
New Delhi, November 21, 2020
COVID 19-driven reforms can raise India's medium-term growth; US President-elect Joe Biden has said he wants to make sure that China plays by the rules and announced that his administration will rejoin the World Health Organisation; Pfizer approaches USFDA to secure emergency use authorisation for COVID vaccine. Watch this and more news on News Blast.


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


Reuters
November 20, 2020
WHO suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients


Reuters
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise


PB Jayakumar
November 18, 2020
Cipla will sell these kits across 25 markets in Asia, Middle-East and North Africa, Latin America, EU and Australia


Niti Kiran
November 17, 2020
\"The strong growth for Glenmark, Cipla and Cadila can be attributed to COVID-19-related products such as favipiravir, remdesivir and tocilizumab,\" said a Nomura report


BusinessToday.In
November 9, 2020
Researchers made their discovery while developing highly sensitive antibody tests for COVID-19. They compared the blood of COVID-19 patients with that of patients who had not had the disease


Reuters
November 9, 2020
Remdesivir was developed by US drugmaker Gilead Sciences, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of treatment


Chitranjan Kumar
November 6, 2020
Cipla Q2 results: India business grew by 17 per cent YoY and 33 per cent QoQ on the back of strong growth across businesses and continued servicing of patients with COVID-19 portfolio


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PAGES 1 OF 15  12345